Cao and Qu
JOCArticle
cis-2-(2,2-Dibromoacetoxy)cyclohexyl isobutyrate (7b): yield
95%; 1H NMR (400 MHz, CDCl3) δ 5.82 (s, 1H), 5.16-5.17 (m,
1H), 5.02 (dt, J = 3.0, 9.2 Hz, 1H), 2.54 (septet, J = 7.0 Hz, 1H),
1.84-1.99 (m, 2H), 1.66-1.74 (m, 4H), 1.42-1.54 (m, 2H), 1.17
(dd, J = 2.8, 7.0 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 176.2,
163.9, 74.4, 70.6, 34.1, 32.7, 27.7, 27.1, 22.1, 20.9, 19.0, 18.9;
HRMS (ESI) for C12H18Br2O4 calcd for [M þ Na]þ m/z
128.1, 125.9, 123.1, 118.7, 56.6, 53.1, 35.4, 34.3, 31.6, 31.3, 29.5,
24.6; HRMS (ESI) for C23H33N3O3S calcd for [M þ H]þ m/z
432.2315, found 432.2321.
cis-2-Hydroxycyclopentyl 2,2-dichloroacetate (14a): white so-
lid; mp 46-49 °C; 1H NMR (400 MHz, CDCl3) δ 6.01 (s, 1H),
5.09-5.13 (m, 1H), 4.25-4.29 (m, 1H), 1.84-2.06 (m, 5H),
1.69-1.78 (m, 1H), 1.58-1.65 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 164.3, 80.0, 73.3, 64.4, 30.6, 27.8, 19.3; HRMS (ESI)
for C7H10Cl2O3 calcd for [M þ Na]þ m/z 234.9899, found
234.9902.
cis-2-(2,2-Dichloroacetoxy)cyclopentyl isobutyrate (14b): yield
85%; 1H NMR (400 MHz, CDCl3) δ 5.93 (s, 1H), 5.27-5.31 (m,
1H), 5.14-5.19 (m, 1H), 2.53 (septet, J = 7.0 Hz, 1H), 2.01-2.08
(m, 2H), 1.77-1.98 (m, 3H), 1.63-1.72 (m, 1H), 1.16 (d, J = 7.0
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 176.4, 163.8, 77.5, 73.8,
64.3, 33.9, 29.7, 28.1, 27.8, 19.1, 18.8; HRMS (ESI) for C11H16-
406.9464, found 406.9458; [R]20 -6.8 (c 1.0, CH2Cl2) 73:27
D
er; HPLC (Chiralcel OD-H, hexane:2-propanol = 93:7, flow
rate = 0.4 mL/min) 210 nm, tR = 12.6 min (1S,2R, major), 13.5
min (1R,2S, minor). The absolute stereochemistry was deter-
mined by analogy with that of 6b.
cis-2-Hydroxycyclohexyl 2-bromoacetate (8a): 1H NMR (400
MHz, CDCl3) δ 5.00 (dt, J = 3.0, 8.0 Hz, 1H), 3.88-3.91 (m,
3H), 1.89-1.95 (m, 1H), 1.75-1.82 (m, 2H), 1.60-1.71 (m, 4H),
1.13-1.44 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 166.9, 76.2,
69.0, 30.2, 26.8, 26.1, 21.7, 21.1; HRMS (ESI) for C8H13BrO3
calcd for [M þ Na]þ m/z 258.9940, found 258.9941.
Cl2O4 calcd for [M þ Na]þ m/z 305.0318, found 305.0323; [R]20
D
-4.2 (c 1.0, CH2Cl2) for 83:17 er; GC analysis: Beta DEX 120
column (30 m ꢀ 0.25 mm ꢀ 0.25 μm film thickness), 152 °C for 100
min, 1 deg/min to 190 °C, 11 psi, tR = 63.5 min (1R,2S, minor),
64.8 min (1S,2R, major). The absolute stereochemistry was deter-
mined by analogy with that of 6b.
cis-2-(2-Bromoacetoxy)cyclohexyl isobutyrate (8b): yield 94%;
1H NMR (400 MHz, CDCl3) δ 5.05-5.09 (m, 2H), 3.82 (s, 2H),
2.55 (septet, J = 7.0 Hz, 1H), 1.82-1.91 (m, 2H), 1.64-1.70 (m,
4H), 1.44-1.49 (m, 2H), 1,17 (dd, J = 3.6, 7.0 Hz, 6H); 13C NMR
(100 MHz, CDCl3) δ 176.3, 166.5, 73.2, 70.1, 34.1, 27.6, 27.4, 25.9,
21.6, 21.5, 19.0, 18.9; HRMS (ESI) for C12H19BrO4 calcd for
cis-2-Hydroxycyclopentyl isobutyrate (14c): yield 91%; 1H
NMR (400 MHz, CDCl3) δ 4.97 (q, J = 5.4, 10.8 Hz, 1H), 4.19
(q, J = 4.8, 9.6 Hz, 1H), 2.60 (septet, J = 7.2 Hz, 1H), 1.96-2.04
(m, 1H), 1.83-1.94 (m, 2H), 1.67-1.78 (m, 2H), 1.52-1.61 (m,
2H), 1.19 (dd, J = 2.4, 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3)
δ 177.0, 76.4, 73.2, 34.0, 30.6, 28.1, 19.4, 19.0, 18.9; HRMS (ESI)
for C9H16O3 calcd for [M þ Na]þ m/z 195.0992, found 195.0994;
GC analysis: Gamma DEX 225 column (30 m ꢀ 0.25 mm ꢀ 0.25
μm film thickness), 120 °C for 28 min, 11 psi, tR = 20.1 min
(1R,2S, minor), 20.8 min (1S,2R, major).
[M þ Na]þ m/z 329.0359, found 329.0357; [R]20 -1.3 (c 1.0,
D
CH2Cl2) 60:40 er; GC analysis: Beta DEX 120 column (30 mꢀ
0.25 mm ꢀ 0.25 μm film thickness), 177 °C for 40 min, 3 deg/min to
190 °C, 11 psi, tR = 20.9 min (1R,2S, minor), 21.3 min (1S,2R,
major). The absolute stereochemistry was determined by analogy
with that of 6b.
cis-2-Hydroxy-trans-6-methylcyclohexyl 2,2-dichloroacetate
(9):16 white solid; mp 70-72 °C; 1H NMR (400 MHz, CDCl3)
δ 6.00 (s, 1H), 4.65 (dd, J = 2.6, 10.0 Hz, 1H), 4.09-4.11 (m,
1H), 2.10-2.21 (m, 1H), 1.90-1.96 (m, 1H), 1.75-1.81 (m, 2H),
1.64-1.72 (m, 1H), 1.44-1.54 (m, 2H), 1.04-1.16 (m, 1H), 0.95
(d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.1, 83.8,
67.3, 64.5, 32.5, 31.0, 30.7, 18.7, 17.7; HRMS (ESI) for
C9H14Cl2O3 calcd for [M þ Na]þ m/z 263.0212, found 263.0219.
cis-2-Hydroxy-trans-3-methylcyclohexyl 2,2-dichloroacetate
(10):16 Compound 9 was crystallized from the mixture of
compounds 9 and 10. But pure compound 10 was inseparable
from the mixture of compounds 9 and 10. The NMR data of
compound 10 were deduced from the mixture’s NMR spectrum.
1H NMR (400 MHz, CDCl3) δ 6.01 (s, 1H), 5.22 (br s, 1H),
3.16-3.43 (m, 1H), 2.05-2.10 (m, 1H), 1.76-1.78 (m, 1H),
cis-2-Hydroxycycloheptyl 2,2-dichloroacetate (15a): 1H NMR
(400 MHz, CDCl3) δ 5.99 (s, 1H), 5.09 (dt, J = 2.6, 9.0 Hz, 1H),
4.03-4.06 (m, 1H), 2.03-2.12 (m, 1H), 1.68-1.90 (m, 6H),
1.56-1.64 (m, 2H), 1.42-1.54 (m, 2H); 13C NMR (100 MHz,
CDCl3) δ 164.0, 81.2, 72.0, 64.5, 31.4, 27.0, 26.6, 22.1, 21.7;
HRMS (ESI) for C9H14Cl2O3 calcd for [M þ Na]þ m/z
263.0212, found 263.0210.
cis-2-(2,2-Dichloroacetoxy)cycloheptyl isobutyrate (15b): yield
91%; 1H NMR (400 MHz, CDCl3) δ5.95 (s, 1H), 5.22 (dt, J=2.6,
7.6 Hz, 1H), 5.10 (dt, J= 2.6, 9.0 Hz, 1H), 2.54 (septet, J=7.0 Hz,
1H), 1.93-2.04 (m, 2H), 1.52-1.85 (m, 8H), 1.16 (dd, J = 1.8, 7.0
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 176.2, 163.7, 78.1, 73.7,
64.5, 34.1, 28.5, 28.3, 26.4, 22.4, 22.1, 18.9, 18.8; HRMS (ESI) for
C13H20Cl2O4 calcd for [M þ Na]þ m/z 333.0631, found 333.0634;
1.49-1.68 (m, 5H), 1.26 (br s, 1H), 1.05 (d, J = 6.4 Hz, 3H); 13
C
NMR (100 MHz, CDCl3) δ 164.2, 77.3, 75.9, 64.6, 34.4, 32.3,
28.7, 19.5, 18.3.
[R]20 -5.4 (c 1.0, CH2Cl2) 87:13 er; HPLC (Chiralcel OD-H,
D
hexane:2-propanol = 96:4, flow rate = 0.15 mL/min) 210 nm,
tR = 29.7 min (1S,2R, major), 31.4 min (1R,2S, minor). The
absolute stereochemistry was determined by analogy with that of 6b.
trans-2-Hydroxy-cis-6-methylcyclohexyl 2,2-dichloroacetate
(11):16 1H NMR (400 MHz, CDCl3) δ 6.00 (s, 1H), 4.81 (dd,
J = 4.0, 6.4 Hz, 1H), 3.94-3.97 (m, 1H), 2.26-2.31 (m, 1H),
2.05-2.19 (m, 1H), 1.90 (br s, 1H), 1.46-1.64 (m, 5H), 0.96 (d,
J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 164.2, 81.2,
67.0, 64.5, 30.5, 30. 4, 29.2, 18.8, 14.9; HRMS (ESI) for
C9H14Cl2O3 calcd for [M þ Na]þ m/z 263.0212, found 263.0221.
trans-2-Hydroxy-trans-3-methylcyclohexyl 2,2-dichloroacetate
(12):16 1H NMR (400 MHz, CDCl3) δ 5.96 (s, 1H), 4.96-4.98
(m, 1H), 3.75 (br s, 1H), 2.03-2.08 (m, 1H), 1.92-1.97 (m, 1H),
1.76 (br s, 1H), 1.54-1.58 (m, 3H), 1.47-1.49 (m, 2H), 1.0 (d, J =
6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 162.3, 76.6, 71.9,
64.5, 32.6, 28.4, 26.5, 19.3, 14.9; HRMS (ESI) for C9H14Cl2O3
calcd for [M þ Na]þ m/z 263.0212, found 263.0220.
1
cis-2-Hydroxycyclooctyl 2,2-dichloroacetate (16a): H NMR
(400 MHz, CDCl3) δ 5.98 (s, 1H), 5.16 (dt, J = 2.4, 9.6 Hz, 1H),
4.05 (br s, 1H), 2.12-2.21 (m, 1H), 2.02 (br s, 1H), 1.82-1.93 (m,
2H), 1.48-1.79 (m, 9H); 13C NMR (100 MHz, CDCl3) δ 163.9,
80.8, 71.2, 64.5, 30.2, 26.9, 26.8, 25.3, 24.2, 21.7; HRMS (ESI)
for C10H16Cl2O3 calcd for [M þ Na]þ m/z 277.0369, found
277.0371.
cis-2-(2,2-Dichloroacetoxy)cyclooctyl isobutyrate (16b): yield
93%; 1H NMR (400 MHz, CDCl3) δ 5.93 (s, 1H), 5.23-5.26 (m,
1H), 5.17-5.19 (m, 1H), 2.53 (septet, J = 6.8 Hz, 1H),
2.01-2.09 (m, 2H), 1.61-1.83 (m, 10H), 1.16 (dd, J = 2.4, 6.8
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 176.2, 163.8, 77.5, 72.7,
64.5, 34.1, 28.1, 27.9, 26.3, 25.9, 23.2, 22.4, 18.9, 18.8; HRMS
(ESI) for C14H22Cl2O4 calcd for [M þ Na]þ m/z 347.0787, found
347.0788; [R]20D -2.0 (c 1.0, CH2Cl2) for 85:15 er; HPLC (Chiralcel
OJ-H, hexane:2-propanol = 96:4, flow rate = 0.2 mL/min) 210 nm,
tR = 23.5 min (1S,2R, major), 26.1 min (1R,2S, minor). The
absolute stereochemistry was determined by analogy with that of 6b.
(S)-Methyl 2-(3,5-di-tert-butyl-2-hydroxyphenylthioamido)-
1
3-(1-methyl-1H-imidazol-5-yl)propanoate (13):8. H NMR (400
MHz, CDCl3) δ 7.45 (s, 1H), 7.38 (s, 1H), 7.01 (s, 1H), 6.80 (s,
1H), 5.44-5.48 (m, 1H), 3.85 (s, 3H), 3.56-3.61 (m, 4H), 3.38 (d,
J = 15.6 Hz, 1H), 1.42 (s, 9H), 1.27 (s, 9H); 13C NMR (100
MHz, CDCl3) δ 196.7, 170.7, 154.8, 141.2, 138.7, 138.6, 128.5,
3668 J. Org. Chem. Vol. 75, No. 11, 2010